Dubai,TNM: Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, presented the second-phase expansion plans of Burjeel Medical City to UAE President Sheikh Mohamed bin Zayed Al Nahyan, highlighting the group’s vision to further strengthen the UAE’s healthcare sector.
The UAE President visited the Burjeel Holdings pavilion during the ‘Make it in the Emirates 2026’ forum held in Abu Dhabi, where he was received by Dr. Shamsheer. During the visit, the expansion plans focusing on major investments in medical education and research were explained in detail.
UAE Vice President and Prime Minister and Ruler of Dubai Sheikh Mohammed bin Rashid Al Maktoum, along with Dubai Crown Prince, UAE Deputy Prime Minister and Minister of Defence Sheikh Hamdan bin Mohammed bin Rashid Al Maktoum, also toured the pavilion and reviewed the upcoming projects. Syed Basar Shueb, Managing Director and CEO of IHC, was also present.
.jpeg)
A Heartfelt Meeting and a Vision Revisited
While presenting the expansion roadmap of Burjeel Medical City, Dr. Shamsheer shared memories of an earlier meeting with Sheikh Mohamed bin Zayed Al Nahyan when the medical city project was still in its conceptual stage. He recalled discussing the vision with the UAE leader years ago and said the upcoming expansion represents the continuation of that ambitious dream.
Spread across 387,000 square metres, the new development aims to transform Mohamed bin Zayed City in Abu Dhabi into a world-class healthcare destination.
The next phase of Burjeel Medical City will feature advanced facilities integrating cancer care, medical research, and education. The project is designed to ensure that both UAE nationals and expatriates can access complex and specialised treatments locally without the need to travel abroad.
Major Investment Announcements
The group also announced a Dh700 million investment to expand Life Pharma, part of VPS Healthcare, at KIZAD.
In addition, a new Dh100 million initiative was launched in the field of advanced genetic therapies for rare blood disorders. The platform aims to develop and manufacture such innovative treatments within the UAE itself.
According to the group, these initiatives will further support the UAE’s national vision of becoming a global hub for healthcare innovation.
